- Home
- PANL vs AVIR Comparison
PANL vs AVIR Comparison
Compare PANL & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- AVIR
- Stock Information
- Founded
- PANL 1996
- AVIR 2012
- Country
- PANL United States
- AVIR United States
- Employees
- PANL N/A
- AVIR N/A
- Industry
- PANL Marine Transportation
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- PANL Consumer Discretionary
- AVIR Health Care
- Exchange
- PANL Nasdaq
- AVIR Nasdaq
- Market Cap
- PANL 257.0M
- AVIR 247.5M
- IPO Year
- PANL N/A
- AVIR 2020
- Fundamental
- Price
- PANL $5.01
- AVIR $3.25
- Analyst Decision
- PANL Strong Buy
- AVIR Hold
- Analyst Count
- PANL 1
- AVIR 1
- Target Price
- PANL N/A
- AVIR $6.88
- AVG Volume (30 Days)
- PANL 223.0K
- AVIR 503.8K
- Earning Date
- PANL 11-12-2024
- AVIR 11-07-2024
- Dividend Yield
- PANL 7.98%
- AVIR N/A
- EPS Growth
- PANL N/A
- AVIR N/A
- EPS
- PANL 0.47
- AVIR N/A
- Revenue
- PANL $521,238,386.00
- AVIR N/A
- Revenue This Year
- PANL $8.04
- AVIR N/A
- Revenue Next Year
- PANL $13.05
- AVIR N/A
- P/E Ratio
- PANL $10.60
- AVIR N/A
- Revenue Growth
- PANL 5.23
- AVIR N/A
- 52 Week Low
- PANL $4.82
- AVIR $2.75
- 52 Week High
- PANL $9.53
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- PANL 32.06
- AVIR 53.42
- Support Level
- PANL $4.82
- AVIR $3.10
- Resistance Level
- PANL $5.29
- AVIR $3.32
- Average True Range (ATR)
- PANL 0.17
- AVIR 0.15
- MACD
- PANL -0.02
- AVIR 0.03
- Stochastic Oscillator
- PANL 21.35
- AVIR 88.50
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).